A BILL 
To continue to fund the IMPROVE Initiative through the 
Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘NIH Implementing 
4
a Maternal health and PRegnancy Outcomes Vision for 
5
Everyone Act of 2022’’ or the ‘‘NIH IMPROVE Act’’. 
6
02:40 Apr 22, 2022
H7565
2 
•HR 7565 IH
SEC. 2. IMPROVE INITIATIVE. 
1
Subpart 7 of part C of title IV of the Public Health 
2
Service Act (42 U.S.C. 281 et seq.) is amended by adding 
3
at the end the following: 
4
‘‘SEC. 452H. IMPROVE INITIATIVE. 
5
‘‘(a) IN GENERAL.—The Director of the Institute 
6
may continue to carry out the IMPROVE initiative (here-
7
after in this section referred to as the ‘Initiative’) through 
8
the Institute for the following: 
9
‘‘(1) Advancing research to— 
10
‘‘(A) reduce preventable causes of maternal 
11
mortality and severe maternal morbidity; 
12
‘‘(B) reduce racial, ethnic, and socio-
13
economic disparities in maternal health out-
14
comes; and 
15
‘‘(C) improve health for pregnant and 
16
postpartum individuals before, during, and after 
17
pregnancy. 
18
‘‘(2) Using an integrated approach to under-
19
stand the biological, behavioral, sociocultural, and 
20
structural factors that affect maternal mortality and 
21
severe maternal morbidity by building an evidence 
22
base for improved care and outcomes in specific re-
23
gions of the United States. 
24
02:40 Apr 22, 2022
H7565
3 
•HR 7565 IH
‘‘(3) Targeting health disparities associated 
1
with maternal mortality and severe maternal mor-
2
bidity by— 
3
‘‘(A) implementing and evaluating commu-
4
nity-based interventions for disproportionately 
5
affected individuals; and 
6
‘‘(B) identifying risk factors and the un-
7
derlying biological mechanisms associated with 
8
leading causes of maternal mortality and severe 
9
maternal morbidity in the United States, in-
10
cluding cardiovascular disease, infection and 
11
immunity, and mental health. 
12
‘‘(b) IMPLEMENTATION.—The Director of the Insti-
13
tute may award grants or enter into contracts, cooperative 
14
agreements, or other transactions to carry out subsection 
15
(a), including with researchers from racial and ethnic mi-
16
nority groups (as defined in section 1707(g)(1)). 
17
‘‘(c) APPROPRIATIONS.—There is authorized to be 
18
appropriated to carry out this section $30,000,000 for 
19
each of fiscal years 2023 through 2027.’’. 
20
Æ 
02:40 Apr 22, 2022
H7565
